Literature DB >> 3363656

Biologic significance of cyclosporine metabolites.

B Ryffel1, B M Foxwell, M J Mihatsch, P Donatsch, G Maurer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3363656

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function.

Authors:  J S Bleck; H J Schlitt; U Christians; R Schottmann; C Thiesemann; S Strohmeyer; K Kohlhaw; K Wonigeit; R Pichlmayr; K F Sewing
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Generation of oxygen free radicals during the metabolism of cyclosporine A: a cause-effect relationship with metabolism inhibition.

Authors:  F Serino; J Grevel; K L Napoli; B D Kahan; H W Strobel
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

3.  Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity.

Authors:  U Christians; K Kohlhaw; J Budniak; J S Bleck; R Schottmann; H J Schlitt; V M Almeida; M Deters; K Wonigeit; R Pichlmayr
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

5.  In vitro metabolism of cyclosporin A with rabbit renal or hepatic microsomes: analysis by HPLC-FPIA and HPLC-MS.

Authors:  C Pham-Huy; N Sadeg; T Becue; C Martin; G Mahuzier; J M Warnet; M Hamon; J R Claude
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

6.  Diltiazem co-treatment in renal transplant patients receiving microemulsion cyclosporin.

Authors:  Cyrus R Kumana; Matthew K L Tong; Chun-Sang Li; Ian J Lauder; Joseph S K Lee; Maybelle Kou; Tom Walley; Alan Haycox; Tak Mao Chan
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.